Hugo RAS system brings choice to the U.S., coupled with the full suite of Medtronic surgical offerings, ultimately creating a...
Hugo
On Wednesday, the U.S. Food and Drug Administration (FDA) cleared Medtronic Plc’s (NYSE:MDT) Hugo robotic-assisted surgery (RAS) system for use...
Medtronic has earned U.S. Food and Drug Administration (FDA) clearance for its Hugo robotic-assisted surgery (RAS) system for use in...
The Hugo robotic-assisted surgery system now has FDA clearance for urologic procedures. Medtronic (NYSE: MDT) + announced today that the...
On December 3, 2025, the FDA granted clearance to the Hugo robotic-assisted surgery (RAS) system for use in minimally invasive...
The Expand URO IDE study (NCT05696444) met its primary efficacy and safety end points, supporting the use of the Hugo...